15x Better Than Niacinamide? 30% Better Than Vitamin C? Meet Debut's DermCeuticalPRO Ingredients

Debut’s DermCeuticalPRO Collection introduces novel, bio-based ingredients with transformative effects, backed by science and clinical testing.
Debut’s DermCeuticalPRO Collection introduces novel, bio-based ingredients with transformative effects, backed by science and clinical testing.
Wasabi at Adobe Stock

Debut utilizes advanced genomics-based AI to discover groundbreaking ingredients, merging cutting-edge technology with beauty.Debut utilizes advanced genomics-based AI to discover groundbreaking ingredients, merging cutting-edge technology with beauty.DebutJoin us for an exclusive on-demand webinar, Biotech’s New Beauty Heroes, which will introduce Debut's DermCeuticalPRO Collection–a new era of biotech-powered beauty ingredients. Discover scientifically proven, 100% bio-based ingredients that deliver transformative results, enhanced potency and unmatched sustainability.

Key topics include: 

✨ How biotech is revolutionizing beauty with AI-powered ingredient discovery 

✨ The science behind DermCeuticalPRO’s clinical claims and performance 

✨ The growing fusion of beauty, biotech and pharma 

The DermCeuticalPRO range currently comprises a trio of ingredient technologies, including:

  • InflammagePRO, an inflammaging technology that is 15x better than niacinamide at reducing markers of inflammation, per Debut
  •  Barrier RepairPRO, which is 30% better than vitamin C for skin damage repair, according to the company
  • LongevityPRO, which is reportedly 2x better than vitamin C for cellular longevity

Be among the first to explore these game-changing innovations. Plus, the first 100 registrants get 10% off their first contract manufacturing order with Debut's BiotechXBeautyLabs. 

Sign up now for immediate access and to lead the future of beauty!

Meet the Experts

  • Joshua Britton, PhD: Founder and CEO of Debut, pioneering sustainable biotechnology for the beauty industry. Leads a 100+ member team, holds 70+ patents, and has raised $70M in funding from top investors like L’Oréal’s BOLD. Holds advanced degrees from MIT, UC Irvine, and Nottingham University.
  • Taylor Oswald: Director of Ingredient & Product Innovation at Debut with 10+ years of life science experience. Specializes in AI development, novel ingredient discovery, and formulation of high-performing beauty products. Holds a MS in Medical Microbiology from the University of Florida and a BS from Gonzaga University.

5 Key Takeaways for Marketers, Product Developers, R&D Leaders and More...

  1. Biotech Unlocks Next-Gen Ingredients: Debut’s DermCeuticalPRO Collection introduces novel, bio-based ingredients with transformative effects, backed by science and clinical testing.
  2. Enhanced Performance with Sustainability: Precision biotech creates potent, targeted ingredients at lower concentrations, reducing skin sensitization while eliminating reliance on petroleum and cultivated resources.
  3. AI-Powered Innovation: Debut utilizes advanced genomics-based AI to discover groundbreaking ingredients, merging cutting-edge technology with beauty.
  4. Convergence of Biotech and Pharma: The growing overlap between biotech and pharmaceuticals is shaping the future of beauty, delivering science-backed solutions with measurable results.
  5. Custom Formulation Opportunities: Through BiotechXBeautyLabs, brands can access tailored formulations and contract manufacturing services, with early registrants receiving exclusive discounts.

    Sign up now for immediate access and to lead the future of beauty!

    More in Skin Care